Aromatase is a unique cytochrome P-450 enzyme that catalyzed the synthesis of estrone and estradiol from the 4-en-3-one androgens androstenedione (AD) and testosterone. [1] [2] [3] The aromatization process appears to proceed with three oxygenations at the C-19 position of the androgens, followed by the eventual loss of the C-19 angular methyl group and the elimination of the 1b,2b-hydrogens, resulting in aromatization of the A-ring of the androgen molecule to the estrogen. [4] [5] [6] Inhibitors of aromatase are useful in treating estrogen-dependent diseases such as a breast cancer. [7] [8] [9] [10] [11] For this reason, a number of aromatase inhibitors, analogs of the substrate AD, have been described. Among the inhibitors, suicide substrates are of interest due to their high selectivity. 12) 4-hydroxy-, 13) 6-oxo, 14) and 6b-bromo-ADs 15) are the earliest discovered suicide substrates. The three former steroids act by oxygenation of the 19-angular methyl moiety in the inactivation of human placental aromatase in a suicide manner, 12, [16] [17] [18] whereas the inactivation mechanism for the 6b-bromo inhibitor 1 (Fig. 1) , which has a very high affinity to aromatase, is currently unknown.
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On the other hand, Furth et al. previously reported that the 2,2-dimethyl substrate analog 2,2-dimethylAD (3) is an excellent competitive inhibitor of aromatase. 19) In addition, it was also reported that the 2,2-dimethyl analogs of the suicide substrates 4-hydroxyAD 19) and 6-oxoAD 20) lost their enzyme-inactivating ability via a suicide mechanism without diminution of their competitive inhibitory potency. This, along with the previous findings 21) regarding the aromatase reaction of a series of 2-methylAD derivatives, indicates that the 2,2-dimethyl group prevents the aromatase-catalyzed 19-oxygenation of the two suicide substrates, producing a reactive electrophile that binds irreversibly to a nucleophilic residue of the active site of the enzyme.
Taken together, to determine whether or not 19-oxygenation is involved in the suicidal inactivation of aromatase by 6b-bromoAD (1), we focused on the 2,2-dimethyl derivative. This paper describes the synthesis of 2,2-dimethyl-6a-and 6b-bromoADs (4, 5) and their aromatase inactivation ability. Steroids 4 and 5 did not deactivate aromatase in a suicide manner.
MATERIALS AND METHODS

General Methods and Materials
Melting points were measured on a Yanagimoto melting point apparatus and are uncorrected. IR spectra were recorded on a Perkin-Elmer FT-IR 1725X spectrophotometer in KBr pellets. UV spectra were determined in 95% ethanol on a Hitachi 150-20 UV spectrophotometer. 1 H-NMR spectra were obtained in CDCl 3 solution with a JEOL EX 270 (270 MHz) using tetramethylsilane (dϭ0.00) as an internal standard, and mass spectra (MS; electron impact) were obtained with a JEOL JMS-DX 303 spectrometer. Thin-layer chromatography (TLC) was performed on E. Merck precoated silica gel plates (Darmstadt, Germany). Column chromatography was conducted with silica gel (E. Merck, 70-230 mesh).
[ Bromination of 2a a-MethylAD (6) with NBS A solution of compound 6 (50 mg, 0.17 mmol) in benzene (4 ml) containing NBS (50 mg, 0.28 mmol) and benzoyl peroxide (1.6 mg, 7 mmol) was heated under reflux for 10 min. The mixture was poured into 10% Na 2 S 2 O 3 solution, extracted with EtOAc (50 ml), washed with 5% NaHCO 3 and H 2 O, and dried with Na 2 SO 4 . Evaporation of the solvent gave a solid which was purified by preparative TLC (hexane-EtOAc) to give 2-methyl-6a-bromoandrosta-1,4-diene-3,17-dione (10) (6 mg, 6%) as the less polar product, as well as 2-methylandrosta-1,4-diene-3,17-dione (8) 
Preparation of Placental Microsomes
Human term placental microsomes (particles sedimenting at 105000ϫg for 60 min) were obtained as described by Ryan. 23) They were washed once with 0.5 mM dithiothreitol solution, lyophilized, and stored at Ϫ20°C. No significant loss of aromatase activity occurred over the period of this study (2 months).
Aromatase Assay Procedure Aromatase activity was measured according to the procedure of Süteri and Thompson, 24) in which tritiated water released from [1b-3 H]AD into the incubation medium during aromatization was used as an index of the enzyme activity. All incubations were carried out in a 67 mM phosphate buffer, pH 7.5, at a final incubation volume of 0.5 ml. The incubation mixture for the IC 50 experiment contained 180 mM of NADPH, 0.3 mM of the 3 H-labeled substrate (3ϫ10 5 dpm), 20 mg protein of the lyophilized microsomes, various concentrations of each of 2,2-dimethyl steroids 4 and 5, and 25 ml of MeOH, and the entire mixture was incubated at 37°C for 20 min.
For kinetic assay, various concentrations of each of the inhibitors 4, 5, 8 and 10, 14.1, 17.7, 23.1, 30.5 nM concentrations of the 3 H-labeled substrate, 20 mg protein of the microsomes, and a 5-min incubation time were used. In the timedependent inactivaiton experiment, 1/10 of the incubation mixture was used for assays of the remaining aromatase activity. 25) Incubations were terminated by the addition of 3 ml of CHCl 3 , followed by vortexing for 40 s. After centrifugation at 700ϫg for 5 min, aliquots (0.25 ml) were removed from the water layer and added to the scintillation mixture for the determination of tritiated water production. IC 50 and apparent K i values were calculated using non-linear regression analysis with Grafit software.
26) RESULTS AND DISCUSSION
Chemistry In order to define the effect of the 2,2-dimethyl substitution of 6a-and 6b-bromoADs (1, 2) on not only aromatase inhibition ability in a suicide manner but also the aromatase reaction, their 2,2-dimethyl analogs 4 and 5 were synthesized. Treatment of 2,2-dimethylAD (3) with NBS in the presence of benzoylperoxide according to the previous method, 15) used for the preparation of 6b-bromoAD (1), gave the 6b-bromo derivative 4 in a good yield (Fig. 2) . Compound 4 was heated in EtOH under reflux for 18 h to produce the 6a-isomer 5 (23%). The stereochemistry at C-6 of the products was confirmed by 1 H-NMR spectrometry according to the previous reports. 15, 27) We have previously reported that 2a-methylAD (6) is a good substrate for aromatase, producing 2-methyl estrogen 21) ; thus, we next focused on the synthesis of the 6b- Fig. 2 . Synthesis of 6-Bromo Steroids 4 and 5 bromo derivative of compound 6 to further elucidate a relation of the aromatase-catalyzed 19-oxygenation to the aromatase inactivation caused by a series of 6b-bromoAD derivatives. Treatment of steroid 6 with NBS gave 6a-bromo-2-methyl-1,4-diene steroid 10 (6%), as well as 2-methyl-1,4-diene analogs 8 (31%), but the desired 6b-bromo product was not isolated (Fig. 3) . The configuration of 6a-bromide 10 was determined on the basis of the 1 H-NMR spectrometry. The result revealed that the 2b-position of the 2a-methyl compound 6 was more reactive than the 6b-position toward the NBS bromination. Treatment of the 1,4-diene 8 with NBS did not yield the 6b-bromo product 10, indicating that a portion of the initially produced 2b-bromo compound 7 would be dehydrobrominated to yield the 2-methyl-1,4-diene 8, and further bromination of the intermediate 7 gave 2b,6b-dibromo compound 9, which would be converted immediately into the 6a-bromo-1,4-diene 10 through dehydrobromination, followed by a subsequent isomerization of the 6b-bromo function. Employment of a short reaction time (5 min) and a careful isolation procedure failed to isolate the 6b-bromo isomer of compound 10.
Aromatase Inhibition Inhibition of aromatase activity in human placental microsomes by the 6a-and 6b-bromo steroids 4 and 5 and the 2-methyl-1,4-diene compounds 8 and 10 was initially determined in vitro under enzyme kinetics. The results are given in Table 1 . Aromatase activity in placental microsomes was determined using a radiometric assay in which tritiated water released from [1b-
3 H]AD into the incubation medium during aromatization was measured. 24) To characterize the nature of inhibitor binding to the active site of aromatase, aromatization was measured at several inhibitor and substrate concentrations. LineweaverBurk plots of the results obtained are shown in Fig. 4 . All of these inhibitors prevented aromatase activity in a competitive manner with apparent inhibition constants (K i 's), obtained by analysis of Dixon plots, ranging from 10 to 81 nM ( Table 1) . The 2,2-dimethyl-6b-and 6a-bromo steroids 4 and 5 were extremely powerful, and their affinity to the active site was about 3 times higher than that of the natural substrate AD (apparent K i for 4 and 5 vs. apparent K m for AD, 14 and 10 nM vs. 33 nM). Introduction of a 2,2-dimethyl function to 6b-bromoAD (1) markedly increased the binding affinity to the active site (K i : 68 nM 15) vs. 14 nM for 1 vs. 4), as observed in a series of AD, 19) 4-hydroxyAD, 19 ) and 6-oxoAD, 20) 1880 Vol. 27, No. 11 whereas the same molecular modification of 6a-bromoAD (2) decreased the binding affinity (K i : 3.4 nM 28) vs. 10.0 nM for 2 vs. 5). The results suggest that the two 6-bromides 1 and 2 may bind to the active site in a different manner.
The four synthesized steroids were then tested for their abilities to cause a time-dependent inactivation of aromatase. The 2,2-dimethyl steroids 4 and 5 did not cause a time-dependent inactivation of human placental aromatase in the presence or absence of NADPH in air (Fig. 5) ; in contrast, the 1,4-diene steroids 8 and 10 inactivated aromatase in a time-dependent manner (Fig. 6A) . Pseudo-first-order kinetics were obtained during the first 12 min of the incubation of inhibitors 8 and 10. With increasing inhibitor concentrations, increasing k obsd were obtained for the inhibitors. Double-reciprocal plots of k obsd versus inhibitor concentration gave overall rate constants for inactivation (k inact 's), and the apparent K I 's for the inhibitors (Fig. 6B, Table 2 ). This indicates the formation of a dissociable enzyme-inhibitor complex, followed by unimolecular inactivation. The K I values obtained from the inactivation experiments are 14.4 and 4.8 times greater than the corresponding K i values from the competitive inhibition experiments. The ratio of the K I to the K i suggests that binding of the activated inhibitor, a reactive electrophile, to a nucleophilic residue of the active site, rather than activation of the inhibitor, or production of the electrophile, is rate-determining. Introduction of a methyl group at C-2 of the parent suicide substrate D 1 -AD decreased the inactivation rate, whereas introduction of a bromine atom at C-6a of the 2-methyl steroid 8 increased it two-fold. The k inact of the 6a-bromo-1,4-diene 10 was higher than that of the parent D 1 -AD. AD, the natural substrate for aromatase, prevented the inactivation by steroids 8 and 10, but L-cysteine, a nucleophile, did not protect aromatase from the inactivation (Fig. 7) . Thus, covalent-bond formation between the enzyme and the reactive intermediate appears to occur rapidly at the active site, therefore preventing diffusion of the activated inhibitor into the surrounding media. 6b-BromoAD (1) has been known to be a suicide substrate of aromatase, which inactivates aromatase in a time-dependent manner in the presence of NADPH; in contrast, 6a-bromoAD (2) is a competitive inhibitor without the ability to inactivate aromatase in an irreversible (time-dependent) manner.
28) The present results indicate that the 2,2-dimethyl function blocks the time-dependent inactivation caused by the suicide substrate 6b-bromoAD (1), as observed in the cases of the other suicide substrates 4-hydroxyAD 19) and 6-oxoAD, 20) which involve 19-oxygenation in the inactivation sequence in each. Recently, we have reported that the introduction of a 2,2-dimethyl or 2b-methyl group to AD almost completely blocks the aromatase reaction, as well as production of the 19-hydroxy and/or 19-oxo derivatives; in contrast, 2a-methyl-AD (6) is aromatized to produce 2-methyl estrogen at a rate of about two-thirds that of AD. 21) Based on this, it is likely that a 2b-methyl moiety of the 2,2-dimethyl and 2b-methyl steroids, being oriented in a 1,3-diaxial relation to the 19-methyl group, may sterically change the positioning of the heme of aromatase to result in a failure of oxygen delivery to the 19-position of the steroids. Thus, it is implied that the sequence for the aromatase inactivation by 6b-bromoAD (1) would involve the 19-oxygenation, leading to the production of a reactive electrophile which binds to the nucleophilic residue of the active site.
Introduction of a 2,2-dimethyl group to 6b-bromoAD (1) markedly increased its affinity to aromatase, whereas this structural change blocked the suicide inactivation of aromatase caused by the parent 6b-bromide 1, probably through steric hindrance by the 2b-methyl moiety for the production of the activated intermediate through the 19-oxygenation. Vol. 27, No. 11 Control (inhibitor, 0 mM), ᭺; controlϩAD (1 mM), ᭹; controlϩL-cystein (0.5 mM), ᮀ; inhibitor (4 mM)ϩAD (1 mM), ; inhibitor (4 mM), ; inhibitor (4 mM)ϩL-cystein (0.5 mM), ᭢.
